Figura 2
BIBLIOGRAFÍA
- Huggins C, Stevens J, Hodges CV et al. Studies on prostatic cancer: II. The effects of castration on advanced carcinoma of the prostate gland. Arch Surg. 1941; 43:209.
- Tolis G, Ackman D, Stellos A et al. Tumor growth inhibition in patients with prostatic carcinoma treated with luteinizing hormone-releasing hormone agonists. Proc Natl Acad Sci U S A. 1982; 79(5):1658.
- Holzbeierlein JM, McLaughlin MD, Thrasher JB et al. Complications of androgen deprivation therapy for prostate cancer. Curr Opin Urol 2004; 14:177.
- Tanvetyanon T, Stiff PJ. Management of the adverse effects associated with intravenous bisphosphonates. Ann Oncol 2006; 17:897.
- García-Almodóvar E, Timoner E, Pou A et al. Caso clínicopatológico: varón con neoplasia de próstata y disnea de origen incierto. Medicina Balear 2013; 28 (2): 43-51.
- Lee C, Gianos M, Klaustermeyer WB et al. Diagnosis and management of hypersensitivity reactions related to common cancer chemotherapy agents. Ann Allergy Asthma Immunol 2009; 102:179.